Quizartinib cohort study bridging to hematopoietic stem cell transplantation in patients with FLT3-ITD positive acute myeloid leukemia; QUICHE study.
Latest Information Update: 23 Feb 2022
At a glance
- Drugs Quizartinib (Primary)
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms Quiche
- 22 Feb 2022 Status changed from not yet recruiting to recruiting.
- 05 Apr 2021 New trial record